Artivion AORT Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total revenues by Business | |||||
| APAC | $44.25M+18.9% | $37.2M+10.8% | $33.58M+20.0% | $27.97M+28.9% | |
| EMEA | $151.37M+15.1% | $131.52M+14.5% | $114.81M+10.3% | $104.12M-4.5% | |
| LATAM | $23.97M+9.6% | $21.88M+21.5% | $18.01M+27.2% | $14.16M+39.1% | |
| North America | $221.74M+12.0% | $197.94M+5.5% | $187.6M+12.0% | $167.54M+6.1% | |
| Total revenues by Product | |||||
| Aortic stent grafts | $159.37M+29.5% | $123.08M+14.5% | $107.47M+15.9% | $92.75M+8.6% | |
| On-X | $101.74M+21.1% | $83.98M+12.7% | $74.53M+16.6% | $63.9M+11.4% | |
| Other | $8.11M-12.5% | $9.27M-17.0% | $11.17M+34.3% | $8.32M+2.3% | |
| Surgical sealants | $76.6M+3.7% | $73.9M+8.6% | $68.02M+4.0% | $65.38M-7.5% | |
| Perclot revenues by Geography | |||||
| Foreign | $227.26M+14.5% | $198.54M+13.8% | $174.52M+14.3% | $152.68M+3.4% | |
| UNITED STATES | $214.08M+12.7% | $189.99M+5.9% | $179.49M+11.4% | $161.11M+6.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Artivion break its business down?
- Artivion (AORT) reports total revenues by business across 4 parts — APAC, EMEA, LATAM and North America. Each is extracted from the segment footnotes and tracked over time.
- Where does Artivion's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Artivion's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
